Terms: = Pancreatic cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Treatment
95 results:
1. PW06 suppresses cancer cell metastasis in human pancreatic carcinoma MIA PaCa-2 cells via the inhibitions of p-Akt/mTOR/NF-κB and MMP2/MMP9 signaling pathways in vitro.
Huang YP; Yeh CA; Ma YS; Chen PY; Lai KC; Lien JC; Hsieh WT
Environ Toxicol; 2024 May; 39(5):2768-2781. PubMed ID: 38264921
[TBL] [Abstract] [Full Text] [Related]
2. MYC Deregulation and pten Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast cancer.
Doha ZO; Wang X; Calistri NL; Eng J; Daniel CJ; Ternes L; Kim EN; Pelz C; Munks M; Betts C; Kwon S; Bucher E; Li X; Waugh T; Tatarova Z; Blumberg D; Ko A; Kirchberger N; Pietenpol JA; Sanders ME; Langer EM; Dai MS; Mills G; Chin K; Chang YH; Coussens LM; Gray JW; Heiser LM; Sears RC
Nat Commun; 2023 Sep; 14(1):5665. PubMed ID: 37704631
[TBL] [Abstract] [Full Text] [Related]
3. m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the pten/PI3K/AKT pathway.
Lin K; Zhou E; Shi T; Zhang S; Zhang J; Zheng Z; Pan Y; Gao W; Yu Y
J Exp Clin Cancer Res; 2023 Aug; 42(1):217. PubMed ID: 37605223
[TBL] [Abstract] [Full Text] [Related]
4. Cytomorphologic, immunophenotypical and molecular features of pancreatic acinar cell carcinoma.
Sun T; Gilani S; Jain D; Cai G
Diagn Cytopathol; 2023 Nov; 51(11):674-683. PubMed ID: 37469257
[TBL] [Abstract] [Full Text] [Related]
5. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
6. Molecular and Functional Heterogeneity of Primary pancreatic Neuroendocrine Tumors and Metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
7. Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data.
Boilève A; Faron M; Fodil-Cherif S; Bayle A; Lamartina L; Planchard D; Tselikas L; Kanaan C; Scoazec JY; Ducreux M; Italiano A; Baudin E; Hadoux J
Eur J Cancer; 2023 Jun; 186():122-132. PubMed ID: 37062210
[TBL] [Abstract] [Full Text] [Related]
8. Interim Analysis of a Prospective Validation of 2 Blood-Based Genomic Assessments (PPQ and NETest) to Determine the Clinical Efficacy of
Bodei L; Raj N; Do RK; Mauguen A; Krebs S; Reidy-Lagunes D; Schöder H
J Nucl Med; 2023 Apr; 64(4):567-573. PubMed ID: 36396457
[TBL] [Abstract] [Full Text] [Related]
9. Potential Anti-Tumor Activity of Nardoguaianone L Isolated from
Sang CY; Zheng YD; Ma LM; Wang K; Wang CB; Chai T; Eshbakova KA; Yang JL
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364317
[TBL] [Abstract] [Full Text] [Related]
10. Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant pancreatic cancer.
Goodwin CM; Waters AM; Klomp JE; Javaid S; Bryant KL; Stalnecker CA; Drizyte-Miller K; Papke B; Yang R; Amparo AM; Ozkan-Dagliyan I; Baldelli E; Calvert V; Pierobon M; Sorrentino JA; Beelen AP; Bublitz N; Lüthen M; Wood KC; Petricoin EF; Sers C; McRee AJ; Cox AD; Der CJ
Cancer Res; 2023 Jan; 83(1):141-157. PubMed ID: 36346366
[TBL] [Abstract] [Full Text] [Related]
11. pten regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation.
Chang TM; Chu PY; Lin HY; Huang KW; Hung WC; Shan YS; Chen LT; Tsai HJ
J Biomed Sci; 2022 Nov; 29(1):92. PubMed ID: 36336681
[TBL] [Abstract] [Full Text] [Related]
12. PICT-1 regulates p53 splicing and sensitivity of medullary thyroid carcinoma cells to everolimus.
Bareli Y; Shimon I; Tobar A; Rubinfeld H
J Neuroendocrinol; 2022 Oct; 34(10):e13187. PubMed ID: 36306198
[TBL] [Abstract] [Full Text] [Related]
13. S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT pathway.
Sun Y; Zhang H; Meng J; Guo F; Ren D; Wu H; Jin X
Cell Rep; 2022 Aug; 40(7):111194. PubMed ID: 35977495
[TBL] [Abstract] [Full Text] [Related]
14. Melatonin modulates metabolic adaptation of pancreatic stellate cells subjected to hypoxia.
Estaras M; Martinez R; Garcia A; Ortiz-Placin C; Iovanna JL; Santofimia-Castaño P; Gonzalez A
Biochem Pharmacol; 2022 Aug; 202():115118. PubMed ID: 35671789
[TBL] [Abstract] [Full Text] [Related]
15. Synthesis of 3-N-/O-/S-methyl-imidazo[1,2-a] pyridine derivatives for caspase-3 mediated apoptosis induced anticancer activity.
Singh D; Yodun T; Kumar G; Ahmad Tali J; Tiwari H; Singh J; Nargotra A; Samykutty A; Singh S; Shankar R
Bioorg Chem; 2022 Aug; 125():105882. PubMed ID: 35660838
[TBL] [Abstract] [Full Text] [Related]
16. Resveratrol inhibits the expression of RYR2 and is a potential treatment for pancreatic cancer.
Jiang H; Wang G; Gu J; Xiao Y; Wang P; Huang X; Sha H; Wang Z; Ma Q
Naunyn Schmiedebergs Arch Pharmacol; 2022 Mar; 395(3):315-324. PubMed ID: 35044499
[TBL] [Abstract] [Full Text] [Related]
17. Anticancer drug resistance: An update and perspective.
Nussinov R; Tsai CJ; Jang H
Drug Resist Updat; 2021 Dec; 59():100796. PubMed ID: 34953682
[TBL] [Abstract] [Full Text] [Related]
18. Positive feedback between lncRNA FLVCR1-AS1 and KLF10 may inhibit pancreatic cancer progression via the pten/AKT pathway.
Lin J; Zhai S; Zou S; Xu Z; Zhang J; Jiang L; Deng X; Chen H; Peng C; Zhang J; Shen B
J Exp Clin Cancer Res; 2021 Oct; 40(1):316. PubMed ID: 34635142
[TBL] [Abstract] [Full Text] [Related]
19. BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma Multiforme.
Xavier MA; Rezende F; Titze-de-Almeida R; Cornelissen B
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439854
[TBL] [Abstract] [Full Text] [Related]
20. Sunitinib and Evofosfamide (TH-302) in Systemic treatment-Naïve Patients with Grade 1/2 Metastatic pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial.
Grande E; Rodriguez-Antona C; López C; Alonso-Gordoa T; Benavent M; Capdevila J; Teulé A; Custodio A; Sevilla I; Hernando J; Gajate P; Molina-Cerrillo J; Díez JJ; Santos M; Lanillos J; García-Carbonero R
Oncologist; 2021 Nov; 26(11):941-949. PubMed ID: 34190375
[TBL] [Abstract] [Full Text] [Related]
[Next]
